North China Pharmaceutical Group Corp - Wikipedia, the ...
North China Pharmaceutical Group Corp. (NCPC) is a leading pharmaceutical manufacturer in China. NCPC, in its early days, was one of the key construction projects during Chinese ...
Pharmaceutical industry in China - Wikipedia, the free encyclopedia
In terms of sales, China's top three companies: Sinopharm Group, Shanghai Pharmaceutical Co. and Jiuzhoutong Group Corp., are all shared less than 5% of the national market.
Simcere Pharmaceutical Group - Nanjing China - Company ...
Simcere Pharmaceutical Group Company Profile - View the latest news, market research, credit research, and investment research on Simcere Pharmaceutical Group Nanjing China http ...
Pharmaceuticals in China to 2010 - Market Research ...
Pharmaceutical demand in China will grow 13.6% annually through 2010. Western proprietary ethical drugs will grow the fastest while Western generic ethical medicines will remain ...
China Shineway Pharmaceutical Group Limited
China Shineway Pharmaceutical Group Limited is the largest Chinese medicine injection and soft capsule manufacturer in the PRC. Our shares are listed on the Main Board of Hong Kong ...
China Shineway Pharmaceutical Group Limited (2877 ...
Announcements: 03 Mar 2010: Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 28 February 2010: 09 Feb 2010: Appointment of Independent Non-Executive Director ...
SiteEngine-Sinopharm Information > Introduction to SINOPHARM
China National Pharmaceutical Group Corporation (hereinafter referred to as SINOPHARM), founded on November 26, 1998, is China's largest pharmaceutical group company.
1093 - China Pharmaceutical Group - Financial Analysis ...
Ltd, 1093 - China Pharmaceutical Group Ltd, CHJTF - China Pharmaceutical Group Ltd, 380 - China Pipe Group Ltd, 254 - China Outdoor Media Group Ltd, CHPN - China Polypeptide Group ...
Simcere Receives SFDA Approval to Manufacture and Sell ...
NANJING, China, Feb. 11 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group ( Simcere or the Company ) (NYSE: SCR), a leading pharmaceutical company specializing in the development,
BOC, China Shineway, Sino-Ocean Land: Hong Kong Equity ...
China Shineway Pharmaceutical Group Ltd. (2877 HK): The manufacturer of Chinese medicines was raised to “buy” from “neutral” at Goldman Sachs Group Inc., which said it sees ...
